Astrazeneca (AZN) Cost of Revenue (2009 - 2026)
Astrazeneca's Cost of Revenue was $2.52 billion in Q2 2026, up 2.0% from $2.47 billion a year earlier but down 5.8% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Cost of Revenue (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Cost of Revenue was $18.64 billion through Jun 30, 2026, up 77.1% year-over-year; for FY2025, it came in at $10.63 billion, up 4.2% from FY2024.
- Cost of Revenue shows a five-year compound annual growth rate of 14.9% (FY2020 to FY2025).
- In earlier years, Cost of Revenue was $10.21 billion in FY2024 (+23.5%), $8.27 billion in FY2023 (-33.3%), $12.39 billion in FY2022 (-0.4%) and $12.44 billion in FY2021 (+134.7%).
- Quarterly Cost of Revenue has moved between $1.91 billion (Q1 2023) and $10.63 billion (Q4 2025) over five years.
- Compared with a year earlier, Cost of Revenue has increased for three straight quarters, with growth averaging 47.8% over the last eight quarters.
- The best year-over-year quarter for Cost of Revenue over five years was Q4 2025 (growth of 290.2%); the worst was Q1 2023 (a decline of 45.7%).
- Per Business Quant data, AZN's Cost of Revenue in the three quarters before Q2 2026 was $2.68 billion (Q1 2026), $10.63 billion (Q4 2025) and $2.8 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 489.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.52 Bn |
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 10.63 Bn |
| Sep 30, 2025 | 2.80 Bn |
| Jun 30, 2025 | 2.47 Bn |
| Mar 31, 2025 | 2.24 Bn |
| Dec 31, 2024 | 2.73 Bn |
| Sep 30, 2024 | 3.08 Bn |
| Jun 30, 2024 | 2.18 Bn |
| Mar 31, 2024 | 2.22 Bn |
| Dec 31, 2023 | 2.31 Bn |
| Sep 30, 2023 | 2.10 Bn |
| Jun 30, 2023 | 1.96 Bn |
| Mar 31, 2023 | 1.91 Bn |
| Dec 31, 2022 | 2.90 Bn |
| Sep 30, 2022 | 2.98 Bn |
| Jun 30, 2022 | 3.00 Bn |
| Mar 31, 2022 | 3.51 Bn |
| Dec 31, 2021 | 4.63 Bn |
| Sep 30, 2021 | 3.76 Bn |
API Access
Astrazeneca Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();